Agilent Technologies, Inc. - Diagnostics and Genomics SS CD GlasgowCancerPlus, 96A
The Agilent SureSelect Custom DNA Glasgow Cancer Plus Panel (part number 5191-6952) is designed for targeted next-generation sequencing (NGS) applications. This panel enables comprehensive analysis of genes associated with cancer, supporting high-throughput workflows with 96 reactions per kit. Utilizing Agilents SureSelect target enrichment technology, the panel provides high specificity and uniformity for reliable variant detection. It is optimized for use with Illumina sequencing platforms and is suitable for research applications in oncology, enabling efficient and accurate identification of genetic alterations relevant to cancer research.